288 related articles for article (PubMed ID: 15640330)
1. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.
Iglesias D; Alegre J; Alemán C; Ruíz E; Soriano T; Armadans LI; Segura RM; Anglés A; Monasterio J; de Sevilla TF
Eur Respir J; 2005 Jan; 25(1):104-9. PubMed ID: 15640330
[TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
[TBL] [Abstract][Full Text] [Related]
4. MMP and TIMP expression pattern in pleural effusions of different origins.
Eickelberg O; Sommerfeld CO; Wyser C; Tamm M; Reichenberger F; Bardin PG; Solèr M; Roth M; Perruchoud AP
Am J Respir Crit Care Med; 1997 Dec; 156(6):1987-92. PubMed ID: 9412584
[TBL] [Abstract][Full Text] [Related]
5. Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.
Teixeira LR; Dias MB; Sales RK; Antonangelo L; Alvarenga VA; Puka J; Marchi E; Acencio MM
Lung; 2016 Dec; 194(6):1021-1027. PubMed ID: 27677622
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Oikonomidi S; Kostikas K; Kalomenidis I; Tsilioni I; Daenas C; Gourgoulianis KI; Kiropoulos TS
Respiration; 2010; 80(4):285-91. PubMed ID: 20453486
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Park KJ; Hwang SC; Sheen SS; Oh YJ; Han JH; Lee KB
Respiration; 2005; 72(2):166-75. PubMed ID: 15824527
[TBL] [Abstract][Full Text] [Related]
8. High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.
Sheen P; O'Kane CM; Chaudhary K; Tovar M; Santillan C; Sosa J; Caviedes L; Gilman RH; Stamp G; Friedland JS
Eur Respir J; 2009 Jan; 33(1):134-41. PubMed ID: 18715875
[TBL] [Abstract][Full Text] [Related]
9. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
Lin FC; Chen YC; Chen FJ; Chang SC
Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion].
Moche M; Hui DS; Huse K; Chan KS; Choy DK; Scholz GH; Gosse H; Winkler J; Schauer J; Sack U; Hoheisel G
Pneumologie; 2005 Aug; 59(8):523-8. PubMed ID: 16110415
[TBL] [Abstract][Full Text] [Related]
12. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
14. Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions.
Vatansever S; Gelisgen R; Uzun H; Yurt S; Kosar F
Clin Invest Med; 2009 Aug; 32(4):E293-300. PubMed ID: 19640333
[TBL] [Abstract][Full Text] [Related]
15. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
[TBL] [Abstract][Full Text] [Related]
16. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
[TBL] [Abstract][Full Text] [Related]
17. When pleural potassium exceeds 5.0 mEq/L, high pleural adenosine deaminase levels do not necessarily indicate tuberculous pleuritis.
Kashiwabara K; Okamoto T; Yamane H
Respirology; 2012 Jan; 17(1):92-8. PubMed ID: 21883680
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
19. Role of pleural viscosity in the differential diagnosis of exudative pleural effusion.
Yetkin O; Tek I; Yetkin F; Numanoglu N
Respirology; 2007 Mar; 12(2):267-71. PubMed ID: 17298461
[TBL] [Abstract][Full Text] [Related]
20. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
